Single Exit Price to Rise 2.88% as Industry Warns of Shortages

The single exit price for medicines will rise 2.88% from October. The industry warns rising input costs are straining medicine supply. The single exit price (SEP) of medicines and scheduled substances will rise 2.88% from 1 October. This is the second adjustment this year. South Africa’s pharmaceutical industry warns that rising input costs are squeezing medicine supply and triggering shortages.…

Continue reading with a Health Matters subscription

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in